Sensitivity, Specificity, and Positivity Predictors of the Pneumococcal Urinary Antigen Test in Community-Acquired Pneumonia-Reference-Cited by-同舟云学术

Sensitivity, Specificity, and Positivity Predictors of the Pneumococcal Urinary Antigen Test in Community-Acquired Pneumonia

Published:2015-10 Issue:10 Volume:12 Page:1482-1489
ISSN:2329-6933
Container-title:Annals of the American Thoracic Society
language:en
Short-container-title:Annals ATS

Author:

Molinos Luis,Zalacain Rafael,Menéndez Rosario,Reyes Soledad,Capelastegui Alberto,Cillóniz Catia,Rajas Olga,Borderías Luis,Martín-Villasclaras Juan J.,Bello Salvador,Alfageme Inmaculada,Rodríguez de Castro Felipe,Rello Jordi,Ruiz-Manzano Juan,Gabarrús Albert,Musher Daniel M.,Torres Antoni

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

Reference36 articles.

1. Epidemiology of community-acquired pneumonia in adults: a population-based study

2. Community-acquired pneumonia

3. Prospective Study of the Usefulness of Sputum Gram Stain in the Initial Approach to Community‐Acquired Pneumonia Requiring Hospitalization

4. Blood cultures for community-acquired pneumonia: Are they worthy of two quality measures? A systematic review

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of the value of point-of-care testing for community-acquired pneumonia;Expert Review of Molecular Diagnostics;2024-08-02

2. Diagnosis and Therapy of Community-Acquired Pneumonia in the Emergency Department: A Retrospective Observational Study and Medical Audit;Journal of Clinical Medicine;2024-01-19

3. Microbiology of Severe Community-Acquired Pneumonia and the Role of Rapid Molecular Techniques;Seminars in Respiratory and Critical Care Medicine;2024-01-09

4. Short- and long-term prognosis of patients with community-acquired Legionella or pneumococcal pneumonia diagnosed by urinary antigen testing;International Journal of Infectious Diseases;2023-09

5. Pneumococcal Conjugate Vaccine Does Not Induce Humoral Response When Administrated Within the Six Months After CD19 CAR T-Cell Therapy;Transplantation and Cellular Therapy;2023-04